🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
9.38
-0.22 (-2.29%)
At close: Nov 18, 2026, 4:00 PM EST
9.24
-0.14 (-1.49%)
Pre-market: Nov 19, 2026, 4:01 AM EST

Bicara Therapeutics Market Cap

Bicara Therapeutics has a market cap or net worth of $622.71 million as of November 18, 2026. It is the 12,540th most valuable company in the world and the 2,516th biggest in the United States. Its market cap has decreased by 24.47% in one year.

Market Cap
622.71M
Enterprise Value
181.25M
1-Year Change
-24.47%
Global Rank
Country Rank
#2,516 United States
Category

Chart

Chart

Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $622.71M, a decrease of -33.16%. That is a compound annual growth rate of -16.87%.

History

DateMarket Cap% Change
Nov 18, 2026622.71M-32.46%
Dec 31, 2025921.98M-2.74%
Dec 31, 2024947.92M1.74%
Sep 13, 2024931.70M-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Annexon661.95M
Nuvectis Pharma660.27M
Janux Therapeutics655.27M
Geron644.24M
Olema Oncology632.52M
Design Therapeutics630.12M
Alumis628.33M
DBV Technologies624.05M
Market Cap Rankings